Gene therapy as a novel pharmaceutical intervention for stroke

Current Pharmaceutical Design

Volumn 17, Issue 5, 2011, Pages 424-433

  Ooboshi, Hiroaki ^a  

^a FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Brain; Gene therapy; Gene transfer; Ischemia; Neurogenesis; Stem cell; Stroke; Vector

Indexed keywords

ADENOVIRUS VECTOR; ADRENOMEDULLIN; CALBINDIN; CILIARY NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOOXYGENASE 1; DNA; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUCOSE TRANSPORTER; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; KALLIKREIN; MIDKINE; MONOCYTE CHEMOTACTIC PROTEIN 1; NEURONAL APOPTOSIS INHIBITORY PROTEIN; PROTEIN BCL 2; RETROVIRUS VECTOR; SAGA ANTIGEN; SCATTER FACTOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNINDEXED DRUG; VASCULOTROPIN; VIRUS RNA;

APOPTOSIS; ARTICLE; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL THERAPY; ENCEPHALITIS; GENE TARGETING; GENE THERAPY; GENE VECTOR; HERPES SIMPLEX VIRUS; MUTAGENESIS; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STROKE;

APOPTOSIS; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; NEUROGENESIS; STEM CELL TRANSPLANTATION; STROKE;

EID: 79953298602     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161211795164149     Document Type: Article

References (94)

1. Zabner J, Couture LA, Gregory RJ, Graham SM, Smith AE, Welsh MJ. Adenovirus-mediated gene transfer transiently corrects the chloride transport defect in nasal epithelia of patients with cystic fibrosis. Cell 1993; 75: 207-16.
2. Verma IM, Somia N. Gene therapy promises, problems and prospects. Nature 1997; 389: 239-42.
3. Abbott A. Genetic medicine gets real. Nature 2001; 411: 410-2.
4. Isner JM. Myocardial gene therapy. Nature 2002; 415: 234-9.
5. Heistad DD, Faraci FM. Gene therapy for cerebral vascular disease. Stroke 1996; 27: 1688-93.
6. Isner JM, Vale PR, Symes JF, Losordo DW. Assessment of risks associated with cardiovascular gene therapy in human subjects. Circ Res 2001; 89: 389-400.
7. Schneider MD, French BA. The advent of adenovirus. Gene therapy for cardiovascular disease. Circulation 1993; 88: 1937-42.
8. Trapnell BC. Adenoviral vectors for gene transfer. Adv Drug Deliv Rev 1993; 12: 185-99.
9. Lin H, Parmacek MS, Morle G, Bolling S, Leiden JM. Expression of recombinant genes in myocardium in vivo after direct injection of DNA. Circulation 1990; 82: 2217-21.
10. Wong LF, Ralph GS, Walmsley LE, et al. Lentiviral-mediated delivery of Bcl-2 or GDNF protects against excitotoxicity in the rat hippocampus. Mol Ther 2005; 11: 89-95.
11. Shen F, Su H, Fan Y, et al. Adeno-associated viral-vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. Stroke 2006; 37: 2601-6.
12. Hacein-Bey-Abina S, Hauer J, Lim A, et al. Efficacy of gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2010; 363: 355-64.
13. Okano S, Yonemitsu Y, Shirabe K, et al. Provision of continuous maturation signaling to Dendritic Cells by RIG-I-Stimulating Cytosolic RNA Synthesis of Sendai Virus. J Immunol 2011; 186: 1828-39.
14. Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 1990; 249: 1285-8.
15. Toyoda K, Ooboshi H, Chu Y, et al. Cationic molecules enhance adenovirus-mediated gene transfer to the carotid artery. Stroke 1998; 29: 2181-7.
16. Rios CD, Ooboshi H, Piegors D, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer to normal and atherosclerotic arteries. A novel approach. Arterioscler Thromb Vasc Biol 1995; 15: 2241-5.
17. Ooboshi H, Welsh MJ, Rios CD, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer in vivo to cerebral blood vessels and perivascular tissue. Circ Res 1995; 77: 7-13.
18. Christenson SD, Lake KD, Ooboshi H, Faraci FM, Davidson BL, Heistad DD. Adenovirus-mediated gene transfer to cerebral blood vessels and perivascular tissue in mice. Stroke 1998; 29: 1411-6.
19. Muhonen MG, Ooboshi H, Welsh MJ, Davidson BL, Heistad DD. Gene transfer to cerebral blood vessels after subarachnoid hemorrhage. Stroke 1997; 28: 822-8.
20. Ono S, Date I, Onoda K, et al. Decoy administration of NF-kappaB into the subarachnoid space for cerebral angiopathy. Hum Gene Ther 1998; 9: 1003-11.
21. Toyoda K, Faraci FM, Watanabe Y, et al. Gene transfer of calcitonin gene-related peptide prevents vasoconstriction after subarachnoid hemorrhage. Circ Res 2000 87: 818-24.
22. Khurana VG, Smith LA, Baker TA, Eguchi D, O'Brien T, Katusic ZS. 2002, Protective vasomotor effects of in vivo recombinant endothelial nitric oxide synthase gene expression in a canine model of cerebral vasospasm. Stroke 33: 782-9.
23. Watanabe Y, Chu Y, Andresen JJ, Nakane H, Faraci FM, Heistad DD. Gene transfer of extracellular superoxide dismutase reduces cerebral vasospasm after subarachnoid hemorrhage. Stroke 2003; 34: 434-40.
24. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36: 557-65.
25. Xie Y, Mies G, Hossmann KA. Ischemic threshold of brain protein synthesis after unilateral carotid artery occlusion in gerbils. Stroke 1989; 20: 620-6.
26. Mies G, Kohno K, Hossmann KA. MK-801, a glutamate antagonist, lowers flow threshold for inhibition of protein synthesis after middle cerebral artery occlusion of rat. Neurosci Lett 1993; 155: 65-8.
27. Ooboshi H, Ibayashi S, Takada J, Yao H, Kitazono T, Fujishima M. Adenovirus-mediated gene transfer to ischemic brain. Ischemic flow threshold for transgene expression. Stroke 2001; 32: 1043-7.
28. Takada J, Ooboshi H, Yao H, Kitazono T, Ibayashi S, Iida M. Adenovirus-mediated gene transfer to ischemic brain is augmented in aged rats. Exp Gerontol 2003; 38: 423-9.
29. Lawrence MS, Sun GH, Kunis DM, et al. Overexpression of the glucose transporter gene with a herpes simplex viral vector protects striatal neurons against stroke. J Cereb Blood Flow Metab 1996; 16: 181-5.
30. Yenari MA, Fink SL, Sun GH, et al. Gene therapy with HSP72 is neuroprotective in rat models of stroke and epilepsy. Ann Neurol 1998; 44: 584-91.
31. Hoehn B, Yenari MA, Sapolsky RM, Steinberg GK. Glutathione peroxidase overexpression inhibits cytochrome C release and proapoptotic mediators to protect neurons from experimental stroke. Stroke 2003; 34: 2489-94.
32. Yenari MA, Minami M, Sun GH, et al. Calbindin d28k overexpression protects striatal neurons from transient focal cerebral ischemia. Stroke 2001; 32: 1028-35.
33. Ooboshi H, Chu Y, Rios CD, Faraci FM, Davidson BL, Heistad DD. Altered vascular function following adenovirus-mediated overexpression of endothelial nitric oxide synthase. Am J Physiol 1997; 273: H265-70.
34. Ooboshi H, Toyoda K, Faraci FM, Lang MG, Heistad DD. Improvement of relaxation in an atherosclerotic artery by gene transfer of endothelial nitric oxide synthase. Arterioscler Thromb Vasc Biol 1998; 18: 1752-8.
35. Ooboshi H, Rios CD, Heistad DD. Novel methods for adenovirusmediated gene transfer to blood vessels in vivo. Mol Cell Biochem 1997; 172: 37-46.
36. Kumai Y, Ooboshi H, Kitazono T, Takada J, Ibayashi S, Fujishima M, Iida M. Brain ischemia augments exo-focal transgene expression of adenovirus-mediated gene transfer to ependyma in hypertensive rats. Exp Neurol 2003; 184: 904-11.
37. Betz AL, Yang GY, Davidson BL. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin- 1 receptor antagonist in brain. J Cereb Blood Flow Metab 1995; 15: 547-51.
38. Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997; 94: 2007-12.
39. Kadomatsu K, Tomomura M, Muramatsu T. CDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem Biophys Res Commun 1988; 151: 1312-18
40. Owada K, Sanjo N, Kobayashi T, et al. Midkine inhibits caspasedependent apoptosis via the activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase in cultured neurons. J Neurochem 1999; 73: 2084-92.
41. Takada J, Ooboshi H, Ago T, et al. Postischemic gene transfer of midkine, a neurotrophic factor, protects against focal brain ischemia. Gene Ther 2005; 12: 487-93.
42. Linnik MD, Zahos P, Geschwind MD, Federoff HJ. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke 1995; 26: 1670-4.
43. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999; 19: 819-34.
44. Kumai Y, Ooboshi H, Takada J, et al. Anti-monocyte chemoattractant protein-1 gene therapy protects against focal brain ischemia in hypertensive rats. J Cereb Blood Flow Metab 2004; 24: 1359-68.
45. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006; 113: 2105-12.
46. Hurn PD, Subramanian S, Parker SM, et al. T- and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation. J Cereb Blood Flow Metab 2007; 27: 1798-805.
47. Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin-17-producing gdT cells in the late phase of ischemic brain injury. Nat Med 2009; 15: 946-50.
48. Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009; 15: 192-9.
49. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174: 1209-20.
50. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-22.
51. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS Jr. Interleukin- 10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem 1999; 274: 31868-74.
52. Ooboshi H, Ibayashi S, Shichita T, et al. Postischemic gene transfer of interleukin-10 protects against both focal and global brain ischemia. Circulation 2005; 111: 913-9.
53. del Zoppo GJ. Stroke and neurovascular protection. N Engl J Med 2006; 354 553-5.
54. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
55. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 2003; 112: 1533-40.
56. Su EJ, Fredriksson L, Geyer M, et al. Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke. Nat Med 2008; 14: 731-7.
57. Sumii T, Lo EH. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats. Stroke. 2002; 33: 831-6.
58. Yamashita T, Kamiya T, Deguchi K, et al. Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain. J Cereb Blood Flow Metab 2009; 29: 715-25.
59. Zhang L, Chopp M, Jia L, Cui Y, Lu M, Zhang ZG. Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats. J Cereb Blood Flow Metab 2009; 29: 1816-24.
60. Kumai Y, Ooboshi H, Ibayashi S, et al. Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability. J Cereb Blood Flow Metab 2007; 27: 1152-60.
61. Magnoni S, Baker A, Thomson S, et al. Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury. Gene Ther 2007; 14: 621-5.
62. Chen YH, Chang M, Davidson BL. Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy. Nat Med 2009; 15: 1215-8.
63. Temple S. The development of neural stem cells. Nature 2001; 414: 112-7.
64. Yagita Y, Kitagawa K, Ohtsuki T, et al. Neurogenesis by progenitor cells in the ischemic adult rat hippocampus. Stroke 2001; 32: 1890-6.
65. Nakatomi H, Kuriu T, Okabe S, et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 2002; 110: 429-41.
66. Arvidsson A, Collin T, Kirik D, Kokaia Z, Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat Med 2002; 8: 963-70.
67. Sugiura S, Kitagawa K, Tanaka S, et al. Adenovirus-mediated gene transfer of heparin-binding epidermal growth factor-like growth factor enhances neurogenesis and angiogenesis after focal cerebral ischemia in rats. Stroke 2005; 36: 859-64.
68. Ishikawa E, Ooboshi H, Kumai Y, et al. Midkine gene transfer protects against focal brain ischemia and augments neurogenesis. J Neurol Sci 2009; 285: 78-84.
69. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
70. Kawai H, Yamashita T, Ohta Y, et al. Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain. J Cereb Blood Flow Metab 2010; 30: 1487-93.
71. Zhao LR, Duan WM, Reyes M, Keene CD, Verfaillie CM, Low WC. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol 2002; 174: 11-20.
72. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantationof human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol 2003; 183: 355-66.
73. Ukai R, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. Mesenchymal stem cells derived from peripheral blood protects against ischemia. J Neurotrauma 2007; 24: 508-20.
74. Kawada H, Takizawa S, Takanashi T, et al. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 2006; 113: 701-10.
75. Kurozumi K, Nakamura K, Tamiya T, et al. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 2004; 9: 189-97.
76. Ikeda N, Nonoguchi N, Zhao MZ, et al. Bone marrow stromal cells that enhanced fibroblast growth factor-2 secretion by herpes simplex virus vector improve neurological outcome after transient focal cerebral ischemia in rats. Stroke 2005; 36: 2725-30.
77. Liu H, Honmou O, Harada K, et al. Neuroprotection by PlGF genemodified human mesenchymal stem cells after cerebral ischaemia. Brain 2006; 129: 2734-45.
78. Imitola J, Raddassi K, Park KI, et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004; 101: 18117-22.
79. Xu DG, Crocker SJ, Doucet JP, et al. Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nat Med 1997; 3: 997-1004.
80. Kitagawa H, Sasaki C, Sakai K, et al. Adenovirus-mediated gene transfer of glial cell line-derived neurotrophic factor prevents ischemic brain injury after transient middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1999; 19: 1336-44.
81. Yang GY, Pang L, Ge HL, et al. Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein. J Cereb Blood Flow Metab 2001; 21: 722-33.
82. Hayashi K, Morishita R, Nakagami H, et al. Gene therapy for preventing neuronal death using hepatocyte growth factor: in vivo gene transfer of HGF to subarachnoid space prevents delayed neuronal death in gerbil hippocampal CA1 neurons. Gene Ther 2001; 8: 1167-73.
83. Pang L, Ye W, Che XM, Roessler BJ, Betz AL, Yang GY. Reduction of inflammatory response in the mouse brain with adenoviralmediated transforming growth factor-ss1 expression. Stroke 2001; 32: 544-52.
84. Hermann DM, Kilic E, Kügler S, Isenmann S, Bähr M. Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol Dis 2001; 8: 655-66.
85. Lin H, Lin TN, Cheung WM, et al. Cyclooxygenase-1 and bicistronic cyclooxygenase-1/prostacyclin synthase gene transfer protect against ischemic cerebral infarction. Circulation 2002; 105: 1962-9.
86. Wang X, Li X, Xu L, et al. Up-regulation of secretory leukocyte protease inhibitor (SLPI) in the brain after ischemic stroke: adenoviral expression of SLPI protects brain from ischemic injury. Mol Pharmacol 2003; 64: 833-40.
87. Bellomo M, Adamo EB, Deodato B, et al. Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil. Pharmacol Res 2003; 48: 309-17.
88. Xia CF, Yin H, Borlongan CV, Chao L, Chao J. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis., Hypertension 2004; 43: 452-9.
89. Watanabe T, Okuda Y, Nonoguchi N, et al. Postischemic intraventricular administration of FGF-2 expressing adenoviral vectors improves neurologic outcome and reduces infarct volume after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 2004; 24: 1205-13.
90. Xia CF, Yin H, Borlongan CV, Chao L, Chao J. Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Hum. Gene Ther 2004; 15: 1243-54.
91. Badin RA, Lythgoe MF, van der Weerd L, Thomas DL, Gadian DG, Latchman DS. Neuroprotective effects of virally delivered HSPs in experimental stroke. J Cereb Blood Flow Metab 2006; 26: 371-81.
92. Sun Y, Ouyang YB, Xu L, et al. The carboxyl-terminal domain of inducible Hsp70 protects from ischemic injury in vivo and in vitro. J Cereb Blood Flow Metab 2006; 26: 937-50.
93. Davis AS, Zhao H, Sun GH, Sapolsky RM, Steinberg GK. Gene therapy using SOD1 protects striatal neurons from experimental stroke. Neurosci Lett 2007; 411: 32-6.
94. Zhu W, Fan Y, Frenzel T, et al. Insulin growth factor-1 gene transfer enhances neurovascular remodeling and improves long-term stroke outcome in mice. Stroke 2008; 39: 1254-61.